Moderna hat bei der Europäischen Union die Zulassung seines Impfstoffs für 6- bis 11-Jährige beantragt. (Symbolbild) | Heute.at

Moderna hat bei der Europäischen Union die Zulassung seines Impfstoffs für 6- bis 11-Jährige beantragt. (Symbolbild)

Rob Welham / Camera Press / picturedesk.com

Download von www.picturedesk.com am 09.11.2021 (17:00). Children may soon be vaccinated against COVID-19 after the Moderna vaccine acquired approval in Britain and Europe for use in 12 to 17-year-olds. Britains health regulator, the Medicines and Healthcare products Regulatory Agency MHRA, approved the Moderna COVID-19 vaccine for children aged 12 to 17, on 17th August 2021. The announcement came only days after an announcement that 16 and 17-year-olds in England were to be offered the vaccine. In Europe Moderna was authorised for children aged 12-17 by the European Medicines Agency EMA on 23rd July. Meanwhile the Food & Drug Administration FDA in the US is demanding further data before approval .The Moderna, NIAID vaccine, a vaccine that aims to protect against COVID-19. - 20210818_PD3010 - Rechteinfo: Rights Managed (RM)